Xiandi Meng
- Topics
- RNA Interference and Gene Delivery (7 papers)Immunotherapy and Immune Responses (6 papers)Nanoplatforms for cancer theranostics (4 papers)
- Partner nations
- ChinaSaint Kitts and NevisUnited States
In The Last Decade
Xiandi Meng
15 papers receiving 590 citations
Hit Papers
Peers
Comparison fields: 5 of 67
- Molecular Biology 431
- Biomedical Engineering 116
- Immunology 104
- Genetics 100
- Biomaterials 91
Countries citing papers authored by Xiandi Meng
This map shows the geographic impact of Xiandi Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiandi Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiandi Meng more than expected).
Fields of papers citing papers by Xiandi Meng
This network shows the impact of papers produced by Xiandi Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiandi Meng. The network helps show where Xiandi Meng may publish in the future.
Co-authorship network of co-authors of Xiandi Meng
This figure shows the co-authorship network connecting the top 25 collaborators of Xiandi Meng. A scholar is included among the top collaborators of Xiandi Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiandi Meng. Xiandi Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 7 | |
| 5 | 7 | |
| 6 | 12 | |
| 7 | 1 | |
| 8 | 3 | |
| 9 | 20 | |
| 10 | 8 | |
| 11 | 92 | |
| 12 | 0 | |
| 13 | 9 | |
| 14 | 12 | |
| 15 | 70 | |
| 16 | 38 | |
| 17 | 1 | |
| 18 | Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticlesbreakdown → | 316 |
About Xiandi Meng
Xiandi Meng is a scholar working on Immunology, Biomaterials and Hematology, having authored 18 papers that have together received 600 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), Immunotherapy and Immune Responses (6 papers) and Nanoplatforms for cancer theranostics (4 papers). The work is most often cited by research in Biomaterials (91 citations), Molecular Biology (431 citations) and Business and International Management (11 citations). Xiandi Meng has collaborated with scholars based in China, Saint Kitts and Nevis and United States. Frequent co-authors include Tianmeng Sun, Ming Wang, Jin Chang, Ying Jiang, Qiaobing Xu, Lanqun Mao, Ji Liu, Yong‐Guang Yang, Jialiang Wang and Kuirong Mao. Their work appears in journals such as Advanced Materials, Biomaterials and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.